CCA
Childress Capital Advisors Portfolio holdings
AUM
$397M
This Quarter Return
+12.22%
1 Year Return
+16.71%
3 Year Return
+73.29%
5 Year Return
–
10 Year Return
–
AUM
$301M
AUM Growth
+$301M
(+17%)
Cap. Flow
+$20.6M
Cap. Flow
% of AUM
6.85%
Top 10 Holdings %
Top 10 Hldgs %
54.61%
Holding
199
New
26
Increased
78
Reduced
55
Closed
19
Top Buys
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$2.87M |
| 2 |
Fidelity Value Factor ETF
FVAL
|
$2.54M |
| 3 |
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
|
$1.38M |
| 4 |
Fidelity Blue Chip Growth ETF
FBCG
|
$1.31M |
| 5 |
SPDR S&P Dividend ETF
SDY
|
$1.03M |
Sector Composition
| 1 | Energy | 28.62% |
| 2 | Technology | 7.56% |
| 3 | Healthcare | 6.26% |
| 4 | Financials | 5.67% |
| 5 | Consumer Staples | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Caterpillar
CAT
$196B
| $256K | 0.08% |
+1,068
| New | +$256K |
|
152
Waste Management
WM
$91.2B
| $254K | 0.08% |
1,619
+93
| +6% | +$14.6K |
|
153
Williams Companies
WMB
$70.7B
| $253K | 0.08% |
7,701
-119
| -2% | -$3.92K |
|
154
HCA Healthcare
HCA
$94.5B
| $243K | 0.08% |
+1,011
| New | +$243K |
|
155
Regeneron Pharmaceuticals
REGN
$61.5B
| $240K | 0.08% |
332
+4
| +1% | +$2.89K |
|
156
Ford
F
$46.8B
| $239K | 0.08% |
20,582
+2,112
| +11% | +$24.6K |
|
157
DexCom
DXCM
$29.5B
| $239K | 0.08% |
+2,112
| New | +$239K |
|
158
Marsh & McLennan
MMC
$101B
| $233K | 0.08% |
1,409
-31
| -2% | -$5.13K |
|
159
Vertex Pharmaceuticals
VRTX
$100B
| $231K | 0.08% |
800
+13
| +2% | +$3.75K |
|
160
Blackstone Mortgage Trust
BXMT
$3.36B
| $231K | 0.08% |
10,910
-15,600
| -59% | -$330K |
|
161
Etsy
ETSY
$5.25B
| $231K | 0.08% |
+1,928
| New | +$231K |
|
162
Crown Castle
CCI
$43.2B
| $230K | 0.08% |
1,697
-817
| -32% | -$111K |
|
163
Eaton
ETN
$136B
| $229K | 0.08% |
+1,460
| New | +$229K |
|
164
US Bancorp
USB
$76B
| $227K | 0.08% |
5,214
+11
| +0.2% | +$480 |
|
165
Freeport-McMoran
FCX
$63.7B
| $222K | 0.07% |
+5,850
| New | +$222K |
|
166
Simon Property Group
SPG
$59B
| $221K | 0.07% |
+1,884
| New | +$221K |
|
167
Sherwin-Williams
SHW
$91.2B
| $220K | 0.07% |
+928
| New | +$220K |
|
168
Fiserv
FI
$75.1B
| $219K | 0.07% |
2,170
+154
| +8% | +$15.6K |
|
169
Agilent Technologies
A
$35.7B
| $214K | 0.07% |
+1,433
| New | +$214K |
|
170
Northrop Grumman
NOC
$84.5B
| $214K | 0.07% |
+393
| New | +$214K |
|
171
Moderna
MRNA
$9.37B
| $211K | 0.07% |
+1,176
| New | +$211K |
|
172
AT&T
T
$209B
| $206K | 0.07% |
11,174
-13,454
| -55% | -$248K |
|
173
Sempra
SRE
$53.9B
| $205K | 0.07% |
1,325
-48
| -3% | -$7.42K |
|
174
Norfolk Southern
NSC
$62.8B
| $203K | 0.07% |
+822
| New | +$203K |
|
175
Aon
AON
$79.1B
| $202K | 0.07% |
+674
| New | +$202K |
|